Skip to main content
SpringerLink
Log in

Use of Transcranial Magnetic Stimulation for the Treatment of PTSD

  • Chapter
  • First Online:
Book cover Posttraumatic Stress Disorder and Related Diseases in Combat Veterans

  • 1870 Accesses

Abstract

Symptoms of posttraumatic stress disorder (PTSD) and depression often fail to resolve with traditional interventions using psychotherapy and/or pharmacotherapy. Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation treatment that may offer efficacy for those patients who have not obtained adequate relief from their symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Taylor S. Clinician’s guide to PTSD: a cognitive-behavioral approach. New York: The Guilford Press; 2006.

    Google Scholar 

  2. Staeker J, Leucht S, Laika B, Steimer W Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients. Genet Test Mol Biomarkers. 2014;18(1):20–31.

    Article  CAS  PubMed  Google Scholar 

  3. Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12):6917–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 2002;359(9323):2086–7.

    Article  CAS  PubMed  Google Scholar 

  5. Lencz T, Robinson DG, Napolitano B, et al. DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics. 2010;20(9):569–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Zhang JP, Lencz T, Malhotra AK. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am J Psychiatry. 2010;167(7):763–72.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Bhat S, Dao DT, Terrillion CE, et al. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol.2012;99(1):1–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA. Applications of CYP450 testing in the clinical setting. Mol Diagn Ther. 2013;17(3):165–84.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems and barriers to care. U.S. Army Med Dep J. 2008:7–17.

    Google Scholar 

  10. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2):187–99.

    Article  CAS  PubMed  Google Scholar 

  11. McCann UD, Kimbrell TA, Morgan CM, et al. Repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Arch Gen Psychiatry. 1998;55(3):276–9.

    Article  CAS  PubMed  Google Scholar 

  12. Horvath JC, Perez JM, Forrow L, Fregni F, Pascual-Leone A Transcranial magnetic stimulation: a historical evaluation and future prognosis of therapeutically relevant ethical concerns. J Med Ethics. 2011;37(3):137–43.

    Article  PubMed  Google Scholar 

  13. Bolognini N, Ro T Transcranial magnetic stimulation: disrupting neural activity to alter and assess brain function. J Neurosci. 2010;30(29):9647–50.

    Article  CAS  PubMed  Google Scholar 

  14. Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010;71(8):992–9.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1–16.

    Article  CAS  PubMed  Google Scholar 

  16. George MS, Raman R, Benedek DM, et al. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimul. May-Jun 2014;7(3):421–31.

    Google Scholar 

  17. Rossi S, De Capua A, Tavanti M, Calossi S, Polizzotto NR, Mantovani A, Falzarano V, Bossini L, Passero S, Bartalini S, Ulivelli M. Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients. Biol Psychiatry. 2009;66(1):54–61.

    Google Scholar 

  18. Kim SY, Lee DW, Kim H, Bang E, Chae JH, Choe BY. Chronic repetitive transcranial magnetic stimulation enhances GABAergic and cholinergic metabolism in chronic unpredictable mild stress rat model: (1)H-NMR spectroscopy study at 11.7T. Neurosci Lett. 2014;572:32–7.

    Article  CAS  PubMed  Google Scholar 

  19. Karsen EF, Watts BV, Holtzheimer PE. Review of the effectiveness of transcranial magnetic stimulation for Posttraumatic stress disorder. Brain Stimul. 2014;7(2):151–7.

    Article  PubMed  Google Scholar 

  20. Group TMoP-TSW. VA/DoD Clinical practice guideline for management of Posttraumatic stress. In: Defense DoVAaDo, 2010.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Intrepid Center of Excellence, Walter Reed National Military Medical Center, 8901 Wisconsin Ave, 20889, Bethesda, MD, USA

    Geoffrey G. Grammer MD

  2. Department of Neurology, Booz Allen Hamilton, 22102, McLean, VA, USA

    Jeffrey T. Cole PhD

  3. Department of Psychiatry, Walter Reed National Military Medical Center, 20889, Bethesda, MD, USA

    Cody J. Rall MD

  4. Department of Behavioral Health, Walter Reed National Military Medical Center, 20889, Bethesda, MD, USA

    Caroline C. Scacca MD

Authors
  1. Geoffrey G. Grammer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey T. Cole PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cody J. Rall MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Caroline C. Scacca MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geoffrey G. Grammer MD .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Uniformed Services University of Health Sciences, Bethesda, Maryland, USA

    Elspeth Cameron Ritchie

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Grammer, G., Cole, J., Rall, C., Scacca, C. (2015). Use of Transcranial Magnetic Stimulation for the Treatment of PTSD. In: Ritchie, E. (eds) Posttraumatic Stress Disorder and Related Diseases in Combat Veterans. Springer, Cham. https://doi.org/10.1007/978-3-319-22985-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22985-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22984-3

  • Online ISBN: 978-3-319-22985-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation